Effect of New Evidence on Antithrombotic Therapies in Atrial Fibrillation Patients Who Undergo Percutaneous Coronary Intervention in Alberta, Canada

Background: Trials have addressed the combined use of direct oral anticoagulants (DOACs) and antiplatelets in atrial fibrillation (AF) patients undergoing percutaneous coronary intervention (PCI). These trials may have changed prescribing patterns. Methods: This administrative audit of Albertans wit...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Theresa E. Eberhardt, PharmD, ACPR, Tammy J. Bungard, BSP, PharmD, Michelle M. Graham, MD, FRCPC, FCCS, Michelle Picard, BScPharm, ACPR, Grace T. Wang, MMath, Margaret L. Ackman, BScPharm, PharmD, ACPR, FCSHP
Формат: Artigo
Язык:Inglês
Опубликовано: Elsevier 2022-04-01
Серии:CJC Open
Online-ссылка:http://www.sciencedirect.com/science/article/pii/S2589790X21003565
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы